vs

Side-by-side financial comparison of Babcock & Wilcox Enterprises, Inc. (BW) and VIEMED HEALTHCARE, INC. (VMD). Click either name above to swap in a different company.

Babcock & Wilcox Enterprises, Inc. is the larger business by last-quarter revenue ($113.4M vs $76.2M, roughly 1.5× VIEMED HEALTHCARE, INC.). On growth, VIEMED HEALTHCARE, INC. posted the faster year-over-year revenue change (25.5% vs 0.6%). VIEMED HEALTHCARE, INC. produced more free cash flow last quarter ($9.7M vs $-7.2M). Over the past eight quarters, VIEMED HEALTHCARE, INC.'s revenue compounded faster (22.7% CAGR vs -16.9%).

Babcock & Wilcox Enterprises, Inc. is an American energy technology and service provider that is active and has operations in many international markets with its headquarters in Akron, Ohio. Historically, the company is best known for their steam boilers.

Viemed Healthcare, Inc. is a medical technology firm specializing in respiratory care solutions. It develops, manufactures and distributes portable ventilators, respiratory therapy devices and related support services, catering to acute care, post-acute care and home care segments across North America, Europe and key Asia-Pacific markets for patients with respiratory conditions.

BW vs VMD — Head-to-Head

Bigger by revenue
BW
BW
1.5× larger
BW
$113.4M
$76.2M
VMD
Growing faster (revenue YoY)
VMD
VMD
+24.9% gap
VMD
25.5%
0.6%
BW
More free cash flow
VMD
VMD
$16.9M more FCF
VMD
$9.7M
$-7.2M
BW
Faster 2-yr revenue CAGR
VMD
VMD
Annualised
VMD
22.7%
-16.9%
BW

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
BW
BW
VMD
VMD
Revenue
$113.4M
$76.2M
Net Profit
$5.6M
Gross Margin
20.6%
57.9%
Operating Margin
0.2%
11.0%
Net Margin
7.4%
Revenue YoY
0.6%
25.5%
Net Profit YoY
30.7%
EPS (diluted)
$0.11
$0.14

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
BW
BW
VMD
VMD
Q4 25
$113.4M
$76.2M
Q3 25
$149.0M
$71.9M
Q2 25
$144.1M
$63.1M
Q1 25
$181.2M
$59.1M
Q4 24
$112.7M
$60.7M
Q3 24
$152.6M
$58.0M
Q2 24
$151.4M
$55.0M
Q1 24
$164.3M
$50.6M
Net Profit
BW
BW
VMD
VMD
Q4 25
$5.6M
Q3 25
$35.1M
$3.5M
Q2 25
$-58.5M
$3.2M
Q1 25
$-22.0M
$2.6M
Q4 24
$-63.1M
$4.3M
Q3 24
$-5.3M
$3.9M
Q2 24
$25.4M
$1.5M
Q1 24
$-16.8M
$1.6M
Gross Margin
BW
BW
VMD
VMD
Q4 25
20.6%
57.9%
Q3 25
24.9%
57.5%
Q2 25
30.0%
58.3%
Q1 25
22.1%
56.3%
Q4 24
16.7%
59.5%
Q3 24
23.7%
59.3%
Q2 24
21.8%
59.8%
Q1 24
23.6%
58.9%
Operating Margin
BW
BW
VMD
VMD
Q4 25
0.2%
11.0%
Q3 25
4.4%
7.8%
Q2 25
5.6%
8.1%
Q1 25
3.2%
6.5%
Q4 24
-8.1%
10.6%
Q3 24
1.0%
9.7%
Q2 24
-2.9%
6.6%
Q1 24
3.5%
4.4%
Net Margin
BW
BW
VMD
VMD
Q4 25
7.4%
Q3 25
23.5%
4.9%
Q2 25
-40.6%
5.0%
Q1 25
-12.1%
4.4%
Q4 24
-56.0%
7.1%
Q3 24
-3.5%
6.7%
Q2 24
16.8%
2.7%
Q1 24
-10.2%
3.2%
EPS (diluted)
BW
BW
VMD
VMD
Q4 25
$0.11
$0.14
Q3 25
$0.30
$0.09
Q2 25
$-0.63
$0.08
Q1 25
$-0.26
$0.06
Q4 24
$-0.73
$0.10
Q3 24
$-0.10
$0.10
Q2 24
$0.24
$0.04
Q1 24
$-0.23
$0.04

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
BW
BW
VMD
VMD
Cash + ST InvestmentsLiquidity on hand
$89.5M
$13.5M
Total DebtLower is stronger
Stockholders' EquityBook value
$-131.5M
$141.5M
Total Assets
$662.9M
$199.2M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
BW
BW
VMD
VMD
Q4 25
$89.5M
$13.5M
Q3 25
$25.2M
$11.1M
Q2 25
$23.4M
$20.0M
Q1 25
$23.5M
$10.2M
Q4 24
$26.9M
$17.5M
Q3 24
$30.6M
$11.3M
Q2 24
$95.5M
$8.8M
Q1 24
$43.9M
$7.3M
Stockholders' Equity
BW
BW
VMD
VMD
Q4 25
$-131.5M
$141.5M
Q3 25
$-232.2M
$133.6M
Q2 25
$-309.2M
$139.7M
Q1 25
$-303.0M
$134.8M
Q4 24
$-283.8M
$131.4M
Q3 24
$-203.7M
$125.0M
Q2 24
$-198.9M
$119.4M
Q1 24
$-223.0M
$116.3M
Total Assets
BW
BW
VMD
VMD
Q4 25
$662.9M
$199.2M
Q3 25
$657.9M
$202.4M
Q2 25
$703.5M
$184.6M
Q1 25
$719.7M
$178.1M
Q4 24
$727.0M
$177.1M
Q3 24
$804.6M
$169.5M
Q2 24
$849.1M
$163.9M
Q1 24
$795.5M
$154.9M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
BW
BW
VMD
VMD
Operating Cash FlowLast quarter
$-3.0M
$18.4M
Free Cash FlowOCF − Capex
$-7.2M
$9.7M
FCF MarginFCF / Revenue
-6.3%
12.7%
Capex IntensityCapex / Revenue
3.7%
11.5%
Cash ConversionOCF / Net Profit
3.27×
TTM Free Cash FlowTrailing 4 quarters
$-85.7M
$11.9M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
BW
BW
VMD
VMD
Q4 25
$-3.0M
$18.4M
Q3 25
$-32.1M
$18.4M
Q2 25
$-25.3M
$12.3M
Q1 25
$-8.5M
$2.9M
Q4 24
$-22.5M
$15.0M
Q3 24
$-69.5M
$12.7M
Q2 24
$-11.8M
$10.2M
Q1 24
$-14.9M
$1.2M
Free Cash Flow
BW
BW
VMD
VMD
Q4 25
$-7.2M
$9.7M
Q3 25
$-37.6M
$10.7M
Q2 25
$-28.1M
$4.1M
Q1 25
$-12.8M
$-12.6M
Q4 24
$-23.6M
$3.2M
Q3 24
$-71.6M
$1.7M
Q2 24
$-16.4M
$1.2M
Q1 24
$-18.3M
$-4.8M
FCF Margin
BW
BW
VMD
VMD
Q4 25
-6.3%
12.7%
Q3 25
-25.3%
14.9%
Q2 25
-19.5%
6.5%
Q1 25
-7.1%
-21.4%
Q4 24
-20.9%
5.2%
Q3 24
-46.9%
3.0%
Q2 24
-10.8%
2.3%
Q1 24
-11.2%
-9.5%
Capex Intensity
BW
BW
VMD
VMD
Q4 25
3.7%
11.5%
Q3 25
3.7%
10.6%
Q2 25
1.9%
12.9%
Q1 25
2.4%
26.2%
Q4 24
1.0%
19.5%
Q3 24
1.4%
19.0%
Q2 24
3.0%
16.3%
Q1 24
2.1%
11.9%
Cash Conversion
BW
BW
VMD
VMD
Q4 25
3.27×
Q3 25
-0.92×
5.23×
Q2 25
3.88×
Q1 25
1.09×
Q4 24
3.47×
Q3 24
3.29×
Q2 24
-0.46×
6.94×
Q1 24
0.73×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

BW
BW

Construction$98.8M87%
Other$14.6M13%

VMD
VMD

Segment breakdown not available.

Related Comparisons